A comprehensive analysis of visfatin drug in type 2 diabetes, insulin resistance, and cardiovascular disease

This review paper aims to provide a comprehensive analysis of the role of the visfatin drug in managing Type 2 diabetes, insulin resistance, and cardiovascular disease. The study explores the mechanism of action of visfatin and its potential therapeutic effects on glucose metabolism, insulin sensitivity, and cardiovascular health. This study integrates pertinent research investigations, clinical experiments, and animal models to assess the effectiveness and safety of visfatin as a therapeutic alternative for these interrelated ailments. The results indicate that visfatin exhibits potential in ameliorating glycemic regulation, augmenting insulin sensitivity, and conceivably mitigating the likelihood of cardiovascular complications among patients afflicted with Type 2 diabetes and insulin resistance.

Hali tarjima qilinmagan